Intech Investment Management LLC increased its position in shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO – Free Report) by 32.7% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 197,226 shares of the biopharmaceutical company’s stock after purchasing an additional 48,559 shares during the quarter. [...]
Halozyme Therapeutics, Inc. $HALO Stake Boosted by Intech Investment Management LLC
